OKYO Pharma to Present at the H.C. Wainwright 6th Annual Ophthalmology Virtual Conference

$OKYOPress releaseJul 21, 2026, 9:00 AM ETRead the release

OKYO Pharma announced that CEO Robert J. Dempsey and CMO Flavio Mantelli will present at the H.C. Wainwright 6th Annual Ophthalmology Virtual Conference on July 22, 2026. The company is a clinical-stage biopharmaceutical firm focused on therapies for neuropathic corneal pain and anterior segment eye diseases.

Key figures

Phase Of Trial: Phase 3
Planned enrollment: 111

AI analysis

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

Upgrade to Pro · $49/mo billed annually

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.